144 related articles for article (PubMed ID: 14557564)
1. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
Voller B; Sycha T; Gustorff B; Schmetterer L; Lehr S; Eichler HG; Auff E; Schnider P
Neurology; 2003 Oct; 61(7):940-4. PubMed ID: 14557564
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
Diener SA; Breimhorst M; Vogt T; Krämer HH; Drummond PD; Geber C; Birklein F
Eur J Pain; 2017 Sep; 21(8):1326-1335. PubMed ID: 28440002
[TBL] [Abstract][Full Text] [Related]
3. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
Lam VY; Wallace M; Schulteis G
J Pain; 2011 Mar; 12(3):323-30. PubMed ID: 20889387
[TBL] [Abstract][Full Text] [Related]
4. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
Gazerani P; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2006 Jun; 122(3):315-325. PubMed ID: 16677761
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
6. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Laitin S; Licht D; Yaksh TL
Anesthesiology; 1997 Jun; 86(6):1262-72. PubMed ID: 9197294
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study.
Wallace MS; Schulteis G
Clin J Pain; 2008; 24(6):544-9. PubMed ID: 18574364
[TBL] [Abstract][Full Text] [Related]
10. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.
Wang H; Bolognese J; Calder N; Baxendale J; Kehler A; Cummings C; Connell J; Herman G
J Pain; 2008 Dec; 9(12):1088-95. PubMed ID: 19038771
[TBL] [Abstract][Full Text] [Related]
11. The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers.
Dirks J; Fabricius P; Petersen KL; Rowbotham MC; Dahl JB
Anesth Analg; 2000 Oct; 91(4):967-72. PubMed ID: 11004058
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
Wallace MS; Quessy S; Schulteis G
Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
[TBL] [Abstract][Full Text] [Related]
14. The effect of chronic oral desipramine on capsaicin-induced allodynia and hyperalgesia: a double-blinded, placebo-controlled, crossover study.
Wallace MS; Barger D; Schulteis G
Anesth Analg; 2002 Oct; 95(4):973-8, table of contents. PubMed ID: 12351279
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover study to evaluate the depth response relationship of intradermal capsaicin-induced pain and hyperalgesia in healthy adult volunteers.
Silberberg A; Moeller-Bertram T; Wallace MS
Pain Med; 2015 Apr; 16(4):745-52. PubMed ID: 25530160
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study.
Ando K; Wallace MS; Braun J; Schulteis G
Reg Anesth Pain Med; 2000; 25(5):468-74. PubMed ID: 11009231
[TBL] [Abstract][Full Text] [Related]
17. Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia.
Yosipovitch G; Maibach HI; Rowbotham MC
Acta Derm Venereol; 1999 Mar; 79(2):118-21. PubMed ID: 10228629
[TBL] [Abstract][Full Text] [Related]
18. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease.
Bruno V; Freitas ME; Mancini D; Lui JP; Miyasaki J; Fox SH
Can J Neurol Sci; 2018 Jan; 45(1):23-29. PubMed ID: 29334040
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans.
Gottrup H; Hansen PO; Arendt-Nielsen L; Jensen TS
Br J Anaesth; 2000 Feb; 84(2):155-62. PubMed ID: 10743446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
